Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bacillus Calmette-Guerin Vaccines
Research from University of Melbourne, Department of Paediatrics provide new insights into Bacillus calmette-guerin vaccines
October 8th, 2008
Researchers detail in 'Influence of BCG vaccine strain on the immune response and protection against tuberculosis,' new data in Bacillus calmette-guerin. According to a study from Australia, "The Bacille Calmette-Guérin (BCG) vaccine has been used for more than 80 years to protect against tuberculosis. Worldwide, over 90% of children are immunized with BCG, making it the most commonly administered vaccine, with more than 120 million doses used each year." "Although new tuberculosis vaccines are under investigation, BCG will remain the cornerstone of the strategy to fight the worsening tuberculosis pandemic for the foreseeable future. The recent delineation of genetic...
Source: Vaccine Weekly (2008-10-08)
|
